Prot# CFTY720D2309: A 24-Month, Dbl-Blind, Rndmzd, Multicenter, Placebo-Cntrld, Parallel-Group Study Comparing the Efficacy&Safety of 0.5mg & 1.25mg Fingolimod(FTY720) Admnstrd Orally 1x Daily vs Placebo in Ptnts w/Relapsing-Remitting Multiple Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date2/6/07 → 4/1/12

Funding

  • Novartis Pharmaceuticals Corporation (CFTY720D2309)